Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF

INTRODUCTION: Hypercoagulability in malignancy increases the risk of thrombosis, but is also involved in cancer progression. Experimental studies suggest that tissue factor (TF) and tissue factor pathway inhibitor (TFPI) are involved in cancer biology as a tumor- promoter and suppressor, respectivel...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res
Autori principali: Tinholt, Mari, Vollan, Hans Kristian Moen, Sahlberg, Kristine Kleivi, Jernström, Sandra, Kaveh, Fatemeh, Lingjærde, Ole Christian, Kåresen, Rolf, Sauer, Torill, Kristensen, Vessela, Børresen-Dale, Anne-Lise, Sandset, Per Morten, Iversen, Nina
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4423106/
https://ncbi.nlm.nih.gov/pubmed/25882602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0548-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi